Legacy Capital Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Legacy Capital Wealth Partners's AMGN Position: Q1 2026 in Review
Legacy Capital Wealth Partners reduced its Amgen (AMGN) stake by 4.1% in Q1 2026, selling an estimated $22.8K and leaving 1,482 shares worth $521K. The position accounts for 0.11% of the portfolio, ranked #199.
Legacy Capital Wealth Partners first reported a position in AMGN in Q1 2023 and has held it in 12 quarters since. The position peaked at $2.58M in Q1 2024. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Legacy Capital Wealth Partners held 1,482 shares of Amgen worth $521K as of Q1 2026.
- Legacy Capital Wealth Partners sold 64 Amgen shares in Q1 2026, an estimated $22.8K.
- Amgen made up 0.11% of Legacy Capital Wealth Partners's portfolio in Q1 2026, its #199 holding.
- Legacy Capital Wealth Partners first reported a position in Amgen in Q1 2023 and has held it in 12 quarters since.
- Legacy Capital Wealth Partners's Amgen position peaked at $2.58M in Q1 2024.
- 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Legacy Capital Wealth Partners's 13F filing for Q1 2026, filed 15 May 2026.